Location History:
- Goteborg, SE (1994)
- Göteborg, SE (2011 - 2017)
- Gothenburg, SE (2019)
- Göteburg, SE (2019)
Company Filing History:
3 out of 3 
1 out of 1 
1 out of 1 Years Active: 1994-2019
Title: Jan Faergemann: Innovator in Dermatological Treatments
Introduction
Jan Faergemann is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of dermatology, particularly in the treatment of skin conditions. With a total of 6 patents to his name, Faergemann's work focuses on innovative solutions for skin atrophy and related issues.
Latest Patents
One of Faergemann's latest patents addresses the treatment of skin atrophy using a combination of triiodothyroacetic acid (TRIAC) and dehydroepiandrosterone (DHEA). This study involved six healthy male volunteers aged 40-65, who were pre-treated with betamethasone valerate cream. The research demonstrated that the combination of TRIAC and DHEA effectively stimulated collagen synthesis in skin pretreated with corticosteroids. This finding suggests that the combination could be a viable treatment for skin atrophy caused by corticosteroids, sun damage, or aging. Another significant patent involves an antimicrobial and anti-inflammatory composition utilizing davanone and 1,8-cineol, showcasing Faergemann's commitment to advancing dermatological therapies.
Career Highlights
Throughout his career, Jan Faergemann has worked with various companies, including Ambria Dermatology AB and Hydro Pharma AB. His experience in these organizations has allowed him to develop and refine his innovative ideas in dermatology.
Collaborations
Faergemann has collaborated with notable individuals in his field, including Thomas Hedner and Gunnar Swanbeck. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Jan Faergemann is a pioneering inventor whose work in dermatology has the potential to transform treatments for skin atrophy and related conditions. His innovative patents reflect a deep understanding of skin health and a commitment to improving patient outcomes.